Litopenaeus vannamei antibacterial and antiviral polypeptide Litomusin81-100 and application thereof

By developing the antibacterial and antiviral peptide Litomusin 81-100 for Litopenaeus vannamei, the problems of bacterial, fungal, and viral diseases in shrimp farming have been solved, achieving efficient and environmentally friendly antiviral and antibacterial effects, which are suitable for the aquaculture field.

CN118878635AActive Publication Date: 2024-11-01XIAMEN UNIV
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411118762.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-15
Publication Date
2024-11-01
Estimated Expiration
2044-08-15

AI Technical Summary

Technical Problem

In existing technologies, disease problems are particularly prominent in shrimp farming, especially biological diseases caused by bacteria, viruses and parasites, which are difficult to control effectively. Furthermore, traditional antibiotics are prone to causing drug resistance and environmental pollution.

Method used

A new antibacterial and antiviral polypeptide, Litomusin 81-100, composed of 20 amino acids, was developed for use in the preparation of antibacterial, antifungal, and antiviral compositions for aquatic feed additives.

Benefits of technology

Litomusin 81-100 exhibits significant inhibitory and bactericidal effects against a variety of bacteria, fungi, and viruses, and is non-toxic to red claw crayfish cells, providing a highly efficient and environmentally friendly antiviral and antibacterial solution.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118878635A_ABST
    Figure CN118878635A_ABST
Patent Text Reader

Abstract

The invention discloses a litopenaeus vannamei antibacterial and antiviral polypeptide Litomusin81-100 and application thereof. The molecular formula of the antibacterial and antiviral polypeptide Litomusin81-100 is C106H183N35O25S1, and the amino acid sequence of the antibacterial and antiviral polypeptide Litomusin81-100 is shown as SEQ ID NO.01. The invention further discloses a preparation method of the antibacterial and antiviral The compound is good in water solubility, remarkable in antibacterial activity on various bacteria and fungi, good in antibacterial effect, high in efficiency, wide in antibacterial spectrum, high in white spot syndrome virus resisting activity, free of toxicity on hematopoietic tissue (Hpt) cells of cherax quadricarinatus and good in application prospect in the aspect of medicine research and development.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of marine molecular biology, and specifically relates to an antibacterial and antiviral peptide of Penaeus vannamei, Litomusin 81-100 and its applications. Background Art

[0002] Since the 1950s, shrimp farming has begun to rise, and in the 1980s, the shrimp farming industry entered a stage of rapid development. Asia is not only the birthplace of shrimp farming, but also the main production area, and its aquaculture output accounts for more than 85% of the global total output. After decades of continuous development, my country's large-scale shrimp farming has ranked first in the world in terms of aquaculture output. Although the shrimp industry is booming and presents a prosperous scene, there are still many problems that cannot be ignored in the farming process, among which the disease problem is particularly challenging. Biological diseases are usually caused by organisms around the host. These organisms mainly refer to pathogens, including bacteria, viruses and parasites.

[0003] Antimicrobial peptides are a class of small molecule peptides naturally present in organisms. They are known for their few enzyme action sites and good thermal stability, and have significant drug-forming properties. These peptides have a broad spectrum of antimicrobial activity, including antiviral effects. Compared with traditional antibiotics, their antimicrobial mechanisms are not likely to lead to microbial resistance, and are not easy to accumulate in organisms. They are a new type of highly efficient and environmentally friendly antimicrobial drug. At present, a variety of antimicrobial peptides derived from shrimp have been reported. For example, ALF has been identified in many crustaceans, has strong antibacterial activity, and can significantly inhibit the transcription and replication of white spot syndrome virus (WSSV). Penaeidin5 in Chinese shrimp has antibacterial activity, and inhibiting its expression will increase the sensitivity of shrimp to WSSV infection. In addition, serum albumin, as the main protein component of hemolymph, has the effect of resisting bacterial and fungal invasion and can inhibit the proliferation of WSSV in shrimp.

[0004] The research and development of new antimicrobial peptides from Penaeus vannamei provides new ideas and methods for the prevention and treatment of aquaculture diseases and the screening of antibacterial and antiviral drugs. Summary of the invention

[0005] The present invention aims to provide a kind of antibacterial and antiviral peptide Litomusin of Litopenaeus vannamei 81-100 .

[0006] Another object of the present invention is to provide the above-mentioned antibacterial and antiviral peptide Litomusin 81-100 application.

[0007] The technical solution of the present invention is as follows:

[0008] Litomusin, an antibacterial and antiviral peptide of Penaeus vannamei 81-100 , and its amino acid sequence is shown in SEQ ID NO.01.

[0009] The above-mentioned antibacterial and antiviral peptide Litomusin from Penaeus vannamei 81-100 Application in the preparation of antibacterial compositions.

[0010] In a preferred embodiment of the present invention, the antibacterial composition has inhibitory and killing effects on Acinetobacter baumannii, Vibrio fluviatilis and Staphylococcus aureus.

[0011] An antibacterial composition, the active ingredient of which includes the above-mentioned antibacterial and antiviral peptide Litomusin from Penaeus vannamei 81-100 .

[0012] The above-mentioned antibacterial and antiviral peptide Litomusin from Penaeus vannamei 81-100 Application in the preparation of antifungal compositions.

[0013] In a preferred embodiment of the present invention, the antifungal composition has inhibitory and killing effects on Cryptococcus neoformans, Fusarium oxysporum, Fusarium solani and Aspergillus niger.

[0014] An antifungal composition, the active ingredient of which includes the above-mentioned antibacterial and antiviral peptide Litomusin from Penaeus vannamei 81-100 .

[0015] The above-mentioned antibacterial and antiviral peptide Litomusin from Penaeus vannamei 81-100 The application of the invention in the preparation of an antiviral composition has the effects of inhibiting and killing white spot syndrome virus.

[0016] An antiviral composition, the active ingredient of which includes the above-mentioned antibacterial and antiviral peptide Litomusin from Penaeus vannamei 81-100 .

[0017] The above-mentioned antibacterial and antiviral peptide Litomusin from Penaeus vannamei 81-100 Application in the preparation of aquatic feed additives.

[0018] An aquatic feed additive, the active ingredient of which includes the above-mentioned antibacterial and antiviral peptide Litomusin of Penaeus vannamei 81-100 .

[0019] The beneficial effects of the present invention are:

[0020] 1. The present invention is composed of 20 amino acids, with the molecular formula being C 106 H 183 N 35 O 25S1, with a molecular weight of 2379.90 Daltons, contains 6 positively charged amino acid residues. Its isoelectric point is predicted to be 12.48 based on the charge of the amino acid residues, and its average hydrophilicity coefficient is -0.120, which means it has good water solubility.

[0021] 2. The present invention has significant antibacterial activity against a variety of bacteria and fungi, has good antibacterial effect, high efficiency, and a broad antibacterial spectrum. In addition, it has strong anti-white spot syndrome virus activity and is non-toxic to red claw crayfish hematopoietic tissue (Hpt) cells, and has good application prospects in drug research and development. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1 The antibacterial and antiviral peptide Litomusin of Litopenaeus vannamei in Example 3 of the present invention 81-100 Stability diagram of antibacterial activity against Staphylococcus aureus, where Figure A is a thermal stability diagram and Figure B is a salt ion stability diagram. The horizontal axis is time (h, hours) and the vertical axis is OD value.

[0023] Figure 2 The MTS-PMS method for detecting the antibacterial and antiviral peptide Litomusin in Litopenaeus vannamei in Example 4 of the present invention 81-100 Toxicity experiment diagram, where the horizontal axis is Litomusin 81-100 The vertical axis is the concentration (μM), and the vertical axis is the cell proliferation rate (%).

[0024] Figure 3 Litomusin, an antibacterial and antiviral peptide from Litopenaeus vannamei 81-100 Anti-white spot syndrome virus activity graph: the horizontal axis represents different groups, and the vertical axis represents the relative level of viral gene transcription. DETAILED DESCRIPTION

[0025] The technical solution of the present invention is further illustrated and described below through specific implementation modes in combination with the accompanying drawings.

[0026] Example 1 Litomusin, an antibacterial and antiviral peptide from Litopenaeus vannamei 81-100 Preparation

[0027] The antibacterial and antiviral polypeptide Litomusin 81-100 The amino acid sequence is:

[0028] Ala-Lys-Arg-Gln-Arg-Ile-Thr-Val-Ser-Ala-Met-Arg-Arg-Leu-Phe-Ala-Lys-Phe-Ser-Leu (SEQ ID NO. 01, AKRGQRITVSAAMRAARLFPALKFSL).

[0029] The antibacterial and antiviral peptide Litomusin with a purity of more than 95% can be obtained by using the existing solid phase chemical synthesis method 81-100 The antibacterial and antiviral peptide Litomusin in this example 81-100 Nanjing GenScript Biotechnology Co., Ltd. was commissioned to obtain the peptide using solid phase chemical synthesis methods and provide testing information such as peptide molecular weight and HPLC.

[0030] Antibacterial and antiviral peptide Litomusin 81-100 The physicochemical parameters are shown in Table 1.

[0031] Table 1 Antibacterial and antiviral peptide Litomusin 81-100 Physical and chemical parameters

[0032]

[0033] From Table 1, we can see that Litomusin 81-100 It has a small molecular weight, good water solubility, and is a cationic polypeptide with a positive charge.

[0034] Example 2 Litomusin, an antibacterial and antiviral peptide from Penaeus vannamei 81-100 Determination of Minimum Inhibition Concentration (MIC) and Minimum Bactericidal Concentration (MBC)

[0035] The strains involved in this embodiment are: Acinetobacter baumannii, Vibrio fluvialis, Staphylococcus aureus, Cryptococcus neoformans, Fusarium oxysporum, Fusarium solani, Aspergillus niger. All strains are from the strain storage center of the Institute of Microbiology, Chinese Academy of Sciences, and are stored in this laboratory.

[0036] The specific method is as follows:

[0037] (1) Spread the preserved bacteria on nutrient broth plates and invert and culture at appropriate temperatures for 18-24 hours; spread Vibrio on 2216 plates and invert and culture at 28°C for 18-24 hours; spread yeast on YPD plates and invert and culture at 28°C for 2-3 days; spread filamentous fungal spores on potato glucose plates and invert and culture at 28°C for 3-7 days.

[0038] (2) The final concentration of bacteria was set to 5×10 5 CFU / mL, adjust the spore concentration so that the final concentration of mold spores is 5×10 4 Pieces / mL.

[0039] (3) The synthesized Litomusin 81-100 The powders were dissolved in sterile ddH2O water, filtered through a 0.22 μm filter membrane, and then the polypeptide concentrations were diluted in multiples to 3 μM, 6 μM, 12 μM, 24 μM, 48 μM, 96 μM, and 192 μM, and placed on ice for later use.

[0040] (4) On a 96-well cell culture plate, a blank control group, a negative control group and an experimental group were set up for each test bacterium, and three parallel groups were set up for each group:

[0041] aBlank control group: 50 μL of peptide sample and 50 μL of culture medium

[0042] b Negative control group: 50 μL sterile ddH2O water and 50 μL bacterial suspension

[0043] c Test group: 50 μL of the tested peptide sample and 50 μL of bacterial suspension

[0044] (5) Place the 96-well cell culture plate in a 28°C incubator and culture for 1-2 days, and observe the MIC results in the experimental group to be tested; after mixing the experimental group to be tested, pipette an appropriate amount of bacterial liquid onto the corresponding solid culture medium plate, culture it upside down at an appropriate temperature for 1-2 days, and observe the MBC results. The antibacterial results are shown in Table 2:

[0045] Table 2 Litomusin, an antibacterial and antiviral peptide of Penaeus vannamei 81-100 Antimicrobial activity

[0046]

[0047] Note: MIC: Minimum inhibitory concentration (μM), expressed as ab. a: The highest peptide concentration at which bacterial growth can be seen with the naked eye; b: The lowest peptide concentration at which bacterial growth is not seen with the naked eye;

[0048] MBC: minimum bactericidal concentration (μM), expressed as ab. a: the highest peptide concentration at which bacterial colonies can be seen growing on the plate; b: the lowest peptide concentration at which no bacterial colonies can be seen growing on the plate.

[0049] Example 3 Litomusin, an antibacterial and antiviral peptide from Penaeus vannamei 81-100 Stability

[0050] In this example, Staphylococcus aureus was selected as the test bacteria, and the antibacterial and antiviral peptide Litomusin was tested on Litopenaeus vannamei. 81-100 The specific method is as follows:

[0051] Thermal stability: First, the antibacterial and antiviral peptide Litomusin 81-100 Heat in a boiling water bath for 0, 10 and 30 min. After cooling, mix the Staphylococcus aureus solution with the heated Litomusin 81-100 Add them to the wells of a 96-well plate and culture them at the optimal growth temperature. After different culture times, use an ELISA reader to monitor the growth status of bacteria at 600nm. The results are as follows Figure 1 A, Litomusin 81-100 Has good thermal stability.

[0052] Salt stability: Staphylococcus aureus liquid, antibacterial and antiviral peptide Litomusin 81-100 The cells were then added to a 96-well plate and incubated at the optimal growth temperature. After incubation for different periods of time, the growth of the bacteria was monitored using an ELISA reader at 600 nm. Figure 1 B, Litomusin 81-100 It has good salt ion stability.

[0053] Example 4 Litomusin, an antibacterial and antiviral peptide from Penaeus vannamei 81-100 Cytotoxicity assay

[0054] In this example, the antibacterial and antiviral peptide Litomusin was expressed in the hematopoietic tissue (Hpt) cells of red claw shrimp. 81-100 Cytotoxicity was measured.

[0055] (1) Collect shrimp hematopoietic tissue (Hpt) cells in good growth state and adjust the cell concentration to 5×10 5 100 μL of cell suspension was added to each well of a 96-well cell culture plate and the plate was placed in an incubator at a suitable temperature for culture.

[0056] (2) Carefully aspirate the culture medium and add different concentrations of Litomusin 81-100 The culture medium was placed in an incubator at an appropriate temperature for 24 h.

[0057] (3) After adding 20 μL of MTS-PMS solution and incubating for 2 h in the dark, the OD was measured using an ELISA reader. 492 Value, evaluation of Litomusin 81-100 of cytotoxicity.

[0058] The results are as follows Figure 2As shown, at the experimental concentration, Litomusin 81-100 It has no cytotoxic effect on the hematopoietic tissue (Hpt) cells of red claw crayfish.

[0059] Example 5: Litomusin, an antibacterial and antiviral peptide from Penaeus vannamei 81-100 Antiviral activity assay

[0060] This example measures the proliferation of white spot syndrome virus and evaluates the efficacy of Litomusin 81-100 Inhibitory effect on viral transcription.

[0061] Different concentrations of antibacterial and antiviral peptides were mixed with white spot syndrome virus and added to the corresponding cells, and a negative control group and a test group were set up, with three parallels in each group. The cells were collected at 6 hours, RNA was extracted, reverse transcribed into cDNA, and viral transcription was detected by qPCR.

[0062] The results are as follows Figure 3 As shown in A and B, Litomusin 81-100 The inhibition rate of transcription of white spot syndrome virus genes ie1 and vp28 can reach more than 50%.

[0063] The above description is only a preferred embodiment of the present invention, and therefore cannot be used to limit the scope of the present invention. That is, equivalent changes and modifications made according to the patent scope of the present invention and the contents of the specification should still fall within the scope of the present invention.

Claims

1. Litomusin, an antibacterial and antiviral peptide from Penaeus vannamei 81-100 , Features: Its amino acid sequence is shown in SEQ ID NO.

01.

2. The antibacterial and antiviral peptide Litomusin of Litopenaeus vannamei according to claim 1 81-100 Application in the preparation of antibacterial compositions.

3. The use according to claim 2, Features: The antibacterial composition has inhibitory and killing effects on Acinetobacter baumannii, Vibrio fluvialis and Staphylococcus aureus.

4. An antibacterial composition, Features: The active ingredient includes the antibacterial and antiviral peptide Litomusin of Penaeus vannamei described in claim 1 81-100 .

5. The antibacterial and antiviral polypeptide Litomusin of Litopenaeus vannamei according to claim 1 81-100 Application in the preparation of antifungal compositions.

6. The use according to claim 5, Features: The antifungal composition has inhibitory and killing effects on Cryptococcus neoformans, Fusarium oxysporum, Fusarium solani and Aspergillus niger.

7. An antifungal composition, Features: The active ingredient includes the antibacterial and antiviral peptide Litomusin of Penaeus vannamei described in claim 1 81-100 .

8. The antibacterial and antiviral polypeptide Litomusin of Litopenaeus vannamei according to claim 1 81-100 Application in the preparation of antiviral compositions, Features: The antiviral composition has the effects of inhibiting and killing white spot syndrome virus.

9. An antiviral composition, Features: The active ingredient includes the antibacterial and antiviral peptide Litomusin of Penaeus vannamei described in claim 1 81-100 .

10. The antibacterial and antiviral polypeptide Litomusin of Litopenaeus vannamei according to claim 1 81-100 Application in the preparation of aquatic feed additives.

11. An aquatic feed additive, Features: The active ingredient includes the antibacterial and antiviral peptide Litomusin of Penaeus vannamei described in claim 1 81-100 .

Citation Information

Patent Citations

  • Litopenaeus vannamei histone antimicrobial peptide and application thereof

    CN107188945A

  • Litopenaeus vannamei calcium ion chelating antibacterial peptide PV13 and application thereof

    CN114315972A